The Role of P62 /Nrf2/Keap1 Signaling Pathway in Lead‐Induced Neurological Dysfunction
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70566 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Dongjie Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Guangxi Medical University, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, NF-E2-Related Factor 2, Signal Transduction, Lead. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Lead (Pb) exposure is recognized for its contribution to the development of neurodegenerative diseases. However, the precise mechanisms underlying Pb‐induced neurological dysfunction remain elusive. This study aimed to investigate the role of oxidative stress and the autophagy‐related P62/kelch like ECH‐associated protein 1 (Keap1)/Nuclear factor erythroid 2‐related factor 2 (Nrf2) pathway in neuronal impairment caused by Pb.
Methods
By employing both in vivo and in vitro approaches, we explored the involvement of the P62/Nrf2/Keap1 pathway in Pb‐induced neurotoxicity.
Results
Our findings demonstrated that Pb exposure triggers excessive production of reactive oxygen species (ROS), upregulates Keap1 protein expressions, promotes Nrf2 degradation, and inhibits expression of antioxidant proteins such as heme Oxygenase‐1 (HO‐1) and glutathione peroxidase (GPx), resulting in oxidative damage in neurons. Furthermore, we observed that the autophagy protein P62 disrupts the normal autophagy process by interacting with the Nrf2/Keap1 axis, leading to an accumulation of Tau, a protein associated with Alzheimer's disease (AD), ultimately resulting in neurodegeneration. However, treatment with the antioxidant N‐acetylcysteine, Nrf2 activator Artemisitene, and autophagy activator Rapamycin attenuated these detrimental changes.
Conclusion
The P62/Nrf2/Keap1 pathway mediates Pb‐induced neuronal dysfunction and highlights its potential as a therapeutic target for mitigating the neurodegenerative effects associated with Pb exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Guangxi Medical University, Nanning, Guangxi, China.
- Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning, China.
ORCID-Profile: Shaojun Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Peng, D., Wei, P., Li, Z., Wei, R., Li, H., & Li, S. (2025). The Role of P62 /Nrf2/Keap1 Signaling Pathway in Lead‐Induced Neurological Dysfunction. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70566
Vancouver
Peng D, Wei P, Li Z, Wei R, Li H, Li S. The Role of P62 /Nrf2/Keap1 Signaling Pathway in Lead‐Induced Neurological Dysfunction. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70566
BibTeX
@article{Peng2025,
author = {Peng, Dongjie and Wei, Peiqi and Li, Zhenning and Wei, Ruokun and Li, Huishuai and Li, Shaojun},
title = {The Role of P62 /Nrf2/Keap1 Signaling Pathway in Lead‐Induced Neurological Dysfunction},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70566}
}
EUVIMED